Index S&P 500 P/E 18.93 EPS (ttm) 28.52 Insider Own 0.41% Shs Outstand 233.07M Perf Week -1.99%
Market Cap 125.19B Forward P/E 12.96 EPS next Y 41.65 Insider Trans -5.50% Shs Float 230.92M Perf Month -0.46%
Income 6.69B PEG 1.57 EPS next Q 9.70 Inst Own 91.65% Short Float 0.77% Perf Quarter 1.02%
Sales 171.72B P/S 0.73 EPS this Y 12.43% Inst Trans 0.08% Short Ratio 1.87 Perf Half Y 4.89%
Book/sh 181.93 P/B 2.97 EPS next Y 11.79% ROA 6.02% Short Interest 1.78M Perf Year 21.09%
Cash/sh - P/C - EPS next 5Y 12.05% ROE 16.65% 52W Range 431.38 - 567.26 Perf YTD 14.48%
Dividend Est. 6.32 (1.17%) P/FCF 152.67 EPS past 5Y 12.18% ROI 10.02% 52W High -4.83% Beta 0.83
Dividend TTM 6.37 (1.18%) Quick Ratio - Sales past 5Y 13.24% Gross Margin - 52W Low 25.15% ATR (14) 9.32
Dividend Ex-Date Sep 10, 2024 Current Ratio 1.49 EPS Y/Y TTM 6.53% Oper. Margin 5.48% RSI (14) 46.96 Volatility 1.51% 1.71%
Employees 104900 Debt/Eq 0.66 Sales Y/Y TTM 3.62% Profit Margin 3.90% Recom 1.61 Target Price 607.61
Option/Short Yes / Yes LT Debt/Eq 0.58 EPS Q/Q 26.46% Payout 23.47% Rel Volume 1.76 Prev Close 538.00
Sales Surprise 0.55% EPS Surprise 1.22% Sales Q/Q -0.06% Earnings Jul 17 BMO Avg Volume 952.17K Price 539.86
SMA20 -1.31% SMA50 0.78% SMA200 4.69% Trades
Volume 1,677,101 Change 0.35%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-18-24 Downgrade BofA Securities
Buy → Neutral
$646 → $530
Jun-24-24 Initiated Morgan Stanley
Overweight
$643
May-30-24 Initiated Robert W. Baird
Outperform
$649
Mar-06-24 Initiated Barclays
Overweight
$584
Jul-12-23 Downgrade Wolfe Research
Outperform → Peer Perform
Apr-27-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$500 → $571
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$547
Mar-28-23 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$523 → $572
Sep-09-22 Upgrade BofA Securities
Neutral → Buy
$535 → $575
Aug-22-22 Upgrade SVB Leerink
Mkt Perform → Outperform
$490 → $580
Sep-13-24 05:08AM
Sep-05-24 12:58PM
07:59AM
Aug-29-24 03:01AM
Aug-25-24 04:22PM
03:09PM
Loading…
Aug-22-24 03:09PM
Aug-20-24 04:40PM
Aug-19-24 08:39AM
Aug-16-24 11:30AM
Aug-13-24 07:08PM
Aug-12-24 10:00AM
Aug-06-24 11:30PM
Aug-02-24 07:43AM
Jul-31-24 05:00PM
Jul-29-24 03:29PM
10:40PM
Loading…
Jul-26-24 10:40PM
Jul-25-24 07:00AM
(The Wall Street Journal)
Jul-23-24 12:23AM
Jul-19-24 12:33PM
(The Wall Street Journal)
Jul-18-24 02:58AM
(Thomson Reuters StreetEvents)
01:01AM
Jul-17-24 01:33PM
12:00PM
10:52AM
10:42AM
10:16AM
(The Wall Street Journal)
10:02AM
(The Wall Street Journal)
09:30AM
07:10AM
06:18AM
06:17AM
Loading…
06:17AM
(The Wall Street Journal)
06:06AM
(Associated Press Finance)
06:00AM
Jul-16-24 09:40AM
Jul-12-24 02:40PM
09:15AM
Jul-10-24 10:00AM
Jul-08-24 01:00PM
12:22PM
Jul-04-24 05:30AM
(The Wall Street Journal)
Jul-03-24 07:50AM
Jun-30-24 11:42AM
Jun-28-24 09:40AM
Jun-27-24 03:56PM
(Investor's Business Daily)
Jun-26-24 04:05PM
Jun-23-24 10:25AM
Jun-20-24 12:22PM
Jun-19-24 03:25PM
12:02PM
Jun-14-24 11:00AM
Jun-13-24 09:16PM
(The Wall Street Journal)
12:56PM
09:45AM
Jun-12-24 12:31PM
09:40AM
Jun-10-24 07:01AM
Jun-07-24 10:16PM
Jun-03-24 11:22AM
May-30-24 04:05PM
May-28-24 09:45AM
May-27-24 09:40AM
May-24-24 05:09PM
May-22-24 05:17PM
May-21-24 12:39PM
May-20-24 04:05PM
May-10-24 09:45AM
May-09-24 09:40AM
09:15AM
May-01-24 09:30AM
Apr-29-24 05:22PM
Apr-26-24 09:50AM
02:25AM
Apr-25-24 05:16PM
12:00PM
Apr-24-24 09:45AM
Apr-23-24 09:40AM
Apr-22-24 07:00AM
(The Wall Street Journal)
Apr-19-24 09:32AM
03:02AM
01:01AM
Apr-18-24 11:49PM
(Thomson Reuters StreetEvents)
04:27PM
03:53PM
12:15PM
11:58AM
11:18AM
10:53AM
10:45AM
(The Wall Street Journal)
09:41AM
09:30AM
08:15AM
07:10AM
06:17AM
06:09AM
(Associated Press Finance)
06:03AM
06:00AM
Apr-17-24 10:33AM
Apr-16-24 06:25PM
(The Wall Street Journal)
12:13PM
Apr-15-24 04:17PM
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PERU RAMIRO G Director Aug 05 '24 Sale 531.52 753 400,235 8,744 Aug 06 05:23 PM RAMIRO G PERU Director Aug 05 '24 Proposed Sale 531.52 753 400,235 Aug 05 04:14 PM BOUDREAUX GAIL President and CEO Jul 22 '24 Sale 500.98 34,000 17,033,395 126,709 Jul 23 05:02 PM Dixon Robert L JR Director Jul 19 '24 Sale 506.76 305 154,562 9,721 Jul 22 04:30 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Option Exercise 238.27 5,473 1,304,052 45,571 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Option Exercise 238.27 2,043 486,786 33,503 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Sale 533.74 14,111 7,531,565 31,460 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Sale 532.44 6,199 3,300,590 27,304 Apr 25 05:05 PM Kendrick Charles Morgan JR EVP & President, Commercial Mar 08 '24 Sale 500.46 2,432 1,217,119 15,840 Mar 12 04:26 PM Penczek Ronald W CAO & Controller Mar 06 '24 Sale 504.58 916 462,195 1,764 Mar 08 04:16 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Option Exercise 166.97 15,000 2,504,550 39,982 Mar 05 04:24 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Sale 500.18 21,095 10,551,297 18,887 Mar 05 04:24 PM PERU RAMIRO G Director Feb 07 '24 Sale 500.00 753 376,500 9,109 Feb 09 04:22 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Option Exercise 311.48 5,492 1,710,648 18,004 Dec 15 04:28 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Sale 484.02 5,492 2,658,238 12,512 Dec 15 04:28 PM Penczek Ronald W CAO & Controller Nov 30 '23 Sale 475.17 1,055 501,304 1,787 Dec 01 04:21 PM Penczek Ronald W CAO & Controller Oct 24 '23 Sale 454.35 64 29,078 2,842 Oct 26 04:15 PM
Index RUT P/E 9.22 EPS (ttm) 3.55 Insider Own 7.90% Shs Outstand 14.17M Perf Week 5.82%
Market Cap 442.37M Forward P/E 8.38 EPS next Y 3.90 Insider Trans -12.25% Shs Float 12.45M Perf Month 14.01%
Income 50.10M PEG 0.31 EPS next Q 0.65 Inst Own 84.96% Short Float 15.40% Perf Quarter 27.46%
Sales 483.37M P/S 0.92 EPS this Y 8.99% Inst Trans -12.55% Short Ratio 7.92 Perf Half Y 13.41%
Book/sh 9.26 P/B 3.54 EPS next Y 4.76% ROA 18.63% Short Interest 1.92M Perf Year 14.97%
Cash/sh 1.86 P/C 17.58 EPS next 5Y 30.00% ROE 42.88% 52W Range 21.24 - 34.80 Perf YTD 42.32%
Dividend Est. 0.80 (2.44%) P/FCF 16.35 EPS past 5Y - ROI 25.33% 52W High -5.98% Beta 1.56
Dividend TTM 0.40 (1.22%) Quick Ratio 0.63 Sales past 5Y 10.95% Gross Margin 54.53% 52W Low 54.05% ATR (14) 1.31
Dividend Ex-Date Sep 26, 2024 Current Ratio 1.46 EPS Y/Y TTM 1.40% Oper. Margin 12.78% RSI (14) 63.91 Volatility 3.85% 4.32%
Employees 4550 Debt/Eq 0.81 Sales Y/Y TTM 0.94% Profit Margin 10.36% Recom 1.00 Target Price 39.67
Option/Short Yes / Yes LT Debt/Eq 0.57 EPS Q/Q 11.55% Payout 0.00% Rel Volume 4.02 Prev Close 32.83
Sales Surprise 2.22% EPS Surprise 11.30% Sales Q/Q 2.36% Earnings Aug 29 BMO Avg Volume 242.12K Price 32.72
SMA20 5.59% SMA50 16.54% SMA200 24.46% Trades
Volume 974,467 Change -0.34%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-20-23 Initiated Jefferies
Buy
$42
Sep-11-23 Initiated Northland Capital
Outperform
Oct-27-17 Downgrade Dougherty & Company
Buy → Neutral
Sep-13-17 Initiated Jefferies
Buy
$12
Jul-28-17 Reiterated Dougherty & Company
Buy
$14.50 → $13.50
Apr-28-17 Reiterated Dougherty & Company
Buy
$13.50 → $14.50
Feb-17-17 Reiterated Dougherty & Company
Buy
$20 → $13.50
Feb-17-17 Downgrade Piper Jaffray
Overweight → Neutral
Dec-31-15 Initiated Sidoti
Buy
Dec-14-15 Initiated Guggenheim
Neutral
Oct-12-09 Upgrade BMO Capital Markets
Market Perform → Outperform
$6
Feb-20-09 Reiterated Needham
Buy
$14 → $13
Feb-20-09 Reiterated Credit Suisse
Neutral
$7 → $4
Jul-09-08 Reiterated Susquehanna Financial
Positive
$14 → $10
May-12-08 Downgrade Credit Suisse
Outperform → Neutral
Oct-19-07 Reiterated Wedbush Morgan
Strong Buy
$32 → $27
Jul-27-07 Reiterated Wedbush Morgan
Strong Buy
$35 → $32
Jul-19-07 Reiterated Stifel Nicolaus
Buy
$33 → $29
Jun-28-07 Upgrade Susquehanna Financial
Neutral → Positive
Jun-19-07 Upgrade Matrix Research
Sell → Hold
Show Previous Ratings
Today 12:45PM
09:40AM
Sep-12-24 04:15PM
Sep-11-24 04:05PM
Sep-06-24 07:22AM
05:35PM
Loading…
Sep-05-24 05:35PM
02:00AM
01:19AM
Sep-04-24 12:45PM
12:00PM
09:40AM
Aug-31-24 03:10AM
Aug-30-24 01:49AM
(Thomson Reuters StreetEvents)
Aug-29-24 05:33PM
07:55AM
06:51AM
Loading…
06:51AM
(Associated Press Finance)
06:45AM
05:15AM
Aug-15-24 04:05PM
Aug-08-24 02:00AM
Aug-06-24 08:00AM
Aug-01-24 10:00AM
Jul-18-24 07:01PM
Jul-16-24 02:18PM
Jul-15-24 01:05AM
Jul-12-24 08:36AM
Jul-11-24 08:00AM
03:05AM
Jun-24-24 04:30PM
Jun-15-24 07:10AM
04:15PM
Loading…
Jun-13-24 04:15PM
Jun-10-24 01:05AM
Jun-04-24 12:30PM
May-31-24 08:05AM
01:34AM
(Thomson Reuters StreetEvents)
May-30-24 10:52AM
07:55AM
06:51AM
(Associated Press Finance)
06:45AM
May-21-24 01:31PM
May-16-24 04:05PM
08:39AM
May-09-24 06:05AM
May-06-24 02:28PM
Apr-30-24 02:06PM
Apr-09-24 01:34PM
Apr-04-24 03:49PM
Mar-27-24 12:01AM
Mar-26-24 05:34PM
Mar-17-24 10:41AM
Mar-14-24 11:07PM
(Thomson Reuters StreetEvents) +16.08%
08:32AM
07:10AM
07:07AM
(Associated Press Finance)
06:45AM
Mar-13-24 05:15PM
Feb-29-24 04:05PM
08:15AM
Feb-22-24 08:32AM
Feb-15-24 05:17PM
01:34PM
10:04AM
Feb-13-24 07:29AM
Feb-12-24 03:59PM
Feb-01-24 06:51PM
Jan-18-24 03:18PM
06:40AM
01:01AM
Jan-17-24 07:20PM
Jan-12-24 11:16AM
Jan-10-24 03:06PM
Jan-08-24 09:00AM
Jan-01-24 04:54PM
Dec-29-23 05:01AM
Dec-22-23 05:02AM
Dec-12-23 02:17PM
Dec-07-23 05:13PM
Dec-01-23 01:25PM
08:56AM
Nov-30-23 08:52AM
07:09AM
06:52AM
(Associated Press Finance)
06:45AM
06:10AM
Nov-29-23 08:21AM
Nov-28-23 11:18AM
Nov-20-23 06:30AM
Nov-16-23 04:05PM
Nov-09-23 03:03PM
Nov-07-23 02:00AM
Nov-03-23 01:26PM
11:18AM
08:37AM
Nov-02-23 09:25AM
08:10AM
Nov-01-23 11:33AM
11:05AM
09:44AM
09:05AM
Oct-31-23 11:27AM
Build-A-Bear Workshop, Inc. engages in the provision of interactive retail-entertainment experiences. It operates through the following segments: Direct-To-Consumer (DTC), Commercial, and International Franchising. The DTC segment includes corporately managed locations and other retail delivery operations including e-commerce sites and temporary stores. The Commercial segment focuses on wholesale product selling and licensing intellectual property for third-party use. The International Franchising segment is involved in royalties, product, and fixture sales from other international operations under franchise agreements. The company was founded by Maxine K. Clark in September 1997 and is headquartered in St. Louis, MO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
John Sharon Price President and CEO Sep 03 '24 Sale 33.32 50,000 1,666,120 465,004 Sep 04 04:17 PM John Sharon Price Officer Sep 03 '24 Proposed Sale 33.38 50,000 1,669,000 Sep 03 05:38 PM Todorovic Vojin Chief Financial Officer Aug 29 '24 Sale 33.37 10,294 343,493 103,330 Aug 30 04:08 PM Todorovic Vojin Officer Aug 29 '24 Proposed Sale 27.87 10,294 286,894 Aug 29 04:43 PM John Sharon Price President and CEO Jul 16 '24 Sale 25.99 41,034 1,066,433 515,004 Jul 18 04:12 PM Carrara George Director Jun 07 '24 Sale 26.34 2,600 68,478 17,473 Jun 11 04:05 PM Hurt J. Christopher Chief Operations Officer Apr 02 '24 Option Exercise 20.47 5,922 121,223 81,709 Apr 03 06:12 PM Hurt J. Christopher Chief Operations Officer Apr 03 '24 Sale 29.11 11,897 346,373 58,890 Apr 03 06:12 PM Hurt J. Christopher Chief Operations Officer Apr 02 '24 Sale 29.35 10,922 320,608 70,787 Apr 03 06:12 PM FENCL ERIC R CAO, Gen. Counsel & Secretary Mar 19 '24 Sale 28.95 16,609 480,887 150,952 Mar 20 04:09 PM FENCL ERIC R CAO, Gen. Counsel & Secretary Mar 18 '24 Sale 29.68 5,722 169,825 167,561 Mar 20 04:09 PM John Sharon Price President and CEO Jan 22 '24 Sale 22.08 71,220 1,572,694 494,976 Jan 22 04:54 PM John Sharon Price President and CEO Jan 18 '24 Sale 22.00 9,235 203,177 574,970 Jan 22 04:54 PM John Sharon Price President and CEO Jan 19 '24 Sale 22.00 8,774 193,028 566,196 Jan 22 04:54 PM John Sharon Price President and CEO Jan 12 '24 Sale 22.27 12,432 276,844 590,349 Jan 17 06:36 PM John Sharon Price President and CEO Jan 16 '24 Sale 22.02 6,144 135,307 584,205 Jan 17 06:36 PM John Sharon Price President and CEO Dec 26 '23 Option Exercise 20.80 17,596 365,997 620,377 Dec 27 04:07 PM John Sharon Price President and CEO Dec 26 '23 Sale 22.90 17,596 402,862 602,781 Dec 27 04:07 PM John Sharon Price President and CEO Dec 19 '23 Option Exercise 20.80 4,433 92,206 607,214 Dec 21 04:53 PM John Sharon Price President and CEO Dec 19 '23 Sale 24.01 4,433 106,423 602,781 Dec 21 04:53 PM Kretchmar Jennifer See Remarks Oct 05 '23 Sale 27.49 21,265 584,566 120,585 Oct 06 05:14 PM Kretchmar Jennifer See Remarks Oct 06 '23 Sale 26.52 6,622 175,631 113,963 Oct 06 05:14 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
